Member Info for mol42

We did have a mention in the pre show article previously noted here but not in the undernoted article from 18 Dec

https://www.wholefoodsmagazine.com/articles/16581-10-macro-trends-from-supplyside-west-2023

A number of names you will recognise and a number of areas where we could have got a mention but didn't

mol

DSM-Firmenich 311023 qtr report extract

The integration of the merged TTH businesses has shown good signs of traction in the areas of cross-selling and the development of new joint concepts. As an example of the latter, a new flavored immunity-supporting dairy drink was launched, combining both taste (strawberry and banana flavor) and ingredients solutions. Other examples of early synergies are for instance in sugar reduction, one of the cornerstone growth platforms of TTH.

https://www.dsm-firmenich.com/corporate/news/press-releases/2023/dsm-firmenich-reports-q3-2023-results.html

mind at our current mc of c23m plus say a premium of even 23m

this enlarged group could make an offer for not only our sweetbiotix but everyhing else and hardly break sweat at the price - this option has of course also existed previously for other prospective suitors and partners but no offers ever made

we are but a very tiny player in this vast market and whilst we have been linked/signed/collaborated in numerous deals since listing our turnover and profitability (lets be honest losses) are unfortunately laughable

still prepared to give 2024 a go though

mol

From 01 Nov 23 rns

The Company's focus for 2023 has been on achieving profitability on a per business unit basis and, once achieved ultimately resulting in overall profitability. This is being driven by a reduction in costs, a focus on existing partners returning to forecast, bringing in new partners particularly in the USA and Asia, and building an e-commerce business through multiple channels to reduce partner dependency. This update seeks to capture the progress made with first generation products since the restructuring of the management team in March in each of these areas.

An update on second generation products will be provided separately in due course.

I have separated the last line from paragraph as released in rns - certainly didn't suggest to me that it would be before Dec 23 nor unfortunately early 2024 - we will see

Prior to that we had 27 Sep 23 half year report

i've edited to sweetbiotix reference only - which basically is the usual opti speak

We are particularly excited about our second-generation products approaching commercialisation given their uniqueness in the marketplace. Our sweet prebiotic fibres, called SweetBiotix® create the opportunity to replace unhealthy calorific and cariogenic sugars with healthy fibres in a wide range of food and beverage products. With growing health concerns over traditional sugars and sweeteners, the commercialisation of SweetBiotix® meets a large global market need.

mol

The difference between an RNS and other pronouncements however made

http://irs.nbtrader.co.uk/ir/SkinBiotix/newsArticle.php?id=2969255&ST=SBTX

https://www.cosmeticsdesign-europe.com/Article/2019/12/03/SkinBioTherapeutics-and-Croda-International-strike-deal-on-skin-microbiome-technology-and-active-cosmetic-development

mol

Https://www.cambridgecommodities.com/home.htm

and scroll down

mol

Latest two news posts

https://www.cambridgecommodities.com/news/view,the-perfect-ingredient-for-gut-health-products_1024.htm

https://www.cambridgecommodities.com/news/view,change-the-way-you-take-your-vitamins-with-our-new-vegan-gummy-range_1022.htm

and whilst they have promoted us in the past neither of above, whilst both headlines could pertain to our products, has nowt to do with us - other than further evidence of ever increasing competition in the market in which we operate

12 years soon since formed and 10 years in July 24 since admission

mol

Mind presumably this is said Shiraz (along with a number of names, previously highlighted, giving reviews prior) of 5th Dec 23

https://www.amazon.co.uk/gp/customer-reviews/R1QFQSE3O8DC7H/ref=cm_cr_dp_d_rvw_ttl?ie=UTF8&ASIN=B0CDX99KCT

mol

Possibly the first noticeable improvement will be in our sales online website (and home website for that matter)

which, despite Stephen's robust defence of Shiraz, I continue to find amateurish

albeit online sales are increasing ( from a very low base) - but could be further and substantially improved imo with very little further spent on website with blogs etc updated on a regular basis and a minimal spend on advertising

mol

Frustrating it is DireCons

as to a bunch of chancers I can think of at least one uk plc listed on aim where that would appear to be the case though I hope I'm wrong - mind time is running out as 31 Dec rapidly approaching

mol

mol

Looks like position filled

From dec 23

Global Supply Chain Director

https://dk.linkedin.com/in/mads-brandt-96849b1?trk=people-guest_people_search-card

think director is used solely in the context of the position (sounds better - at least to some - not me) rather than a director of

probiotix health plc

which still persists in using seborg as head quarters and to this date hasn't explained the apparent subsidiary involving our CEO

https://uk.linkedin.com/company/probiotix-health?trk=public_profile_experience-item_profile-section-card_subtitle-click

mol

Https://www.mealprep.com.au/p/choosing-a-meal-replacement-shake-that-works/

jees shouldn't be too difficult to put the undernoted right

Little information about their ‘patented’ ingredient

mol

I think he is referring to opti.gb.pl which as we know is for opti's shares traded on aquis market

but maybe not and the s is right beside the d - at least on my keyboard - lol

mol

You will get the drift

https://www.youtube.com/watch?v=SO4Ht5gvkGQ

https://www-holos-com-hk.translate.goog/product/cholbiome-bp/?_x_tr_sl=auto&_x_tr_tl=en&_x_tr_hl=en-US&_x_tr_pto=wapp

mol

Cheers martinu

increasing liquidity is difficult in these markets - lol

impossible on aquis

mol

Probably the best appointment

Stephen has made imo

I don't think we will have to wait too many months to guage his impact ( under 12 for sure)

I am now giving it towards end 2024 - mind what do I know - before selling up (all other things being equal)

bw all

mol

Oops meant to note there is no option for retired at companies house (from whence previous info is sourced) so it shows as resigned regardless of reason whereas presumably he retired from said appointments

mol

A useful summary on one page

https://suite.endole.co.uk/insight/people/6704094-mr-graham-lloyd-myers?page=companies

mol

A snippet from an interview from 2015 with Graham

https://www.youtube.com/watch?v=D56EKuzJm4c

I don't intend to become a subscriber to listen to the full 10 mins

mol

Probiotic Bacteria

The invention provides filtered probiotic bacteria lysates derived from Lactobacillus rhamnosus ATCC 53103, or Lactobacillus reuteri ATCC 55730, for manufacture of a medicament and for use in methods of medical and cosmetic treatment, and topical compositions comprising the filtered probiotic lysates. Use in the treatment of infections, including skin infections and methods involving regeneration or repair of the skin barrier are contemplated.

mol

Just thought i'd review the undernoted again (not on facebook myself )

https://www.facebook.com/optibiotix

and certainly an increase in recent posts and i was reasonably impressed with same - albeit few followers

anyway i was struck by post 20 Nov 23 and Tim's experience until i thought i'd seen it before

yep 16 July 2022 on our online store

nevermind it was a good headline

mol